Design of Novel Compounds with the Potential of Dual PPARγ/α Modulation for the Management of Metabolic Syndrome
This study sought to identify a single molecule capable of managing all three manifestations of metabolic syndrome–hyperglycaemia, dyslipidaemia and hypertension. Two Protein Data Bank (PDB) depositions were selected and used to establish the baseline affinity that any designed molecule in this stud...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KenzPub
2017-12-01
|
| Series: | Nuclear Receptor Research |
| Subjects: | |
| Online Access: | http://www.kenzpub.com/journals/nurr/2017/101311/ |